SUBSCRIBE
SUBSCRIBE

Biogen

NEWS
3 Biotechs That Could be Taken Out This Quarter
Business
Biogen Exec Leaves to Put Together and Helm New Biotech Startup
May 11, 2017
 · 
3 min read
Business
How Genentech Could Be A New Threat For Biogen
May 10, 2017
 · 
1 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Business
Biogen’s Ex-CEO George Scangos Left a Very Wealthy Man
April 27, 2017
 · 
2 min read
Business
Biogen Earnings: New Drug Sparks Life
April 27, 2017
 · 
1 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Drug Development
Some Predict Biogen’s Alzheimer’s Drug Will Fail
April 26, 2017
 · 
3 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Business
Fasten Your Seatbelt: Biogen Preps for a Deal-Making Bonanza
April 24, 2017
 · 
3 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Deals
How Biogen Lost Its Chance to Be the Hunter and Became the Hunted in Just a Few Months
April 17, 2017
 · 
4 min read
Bristol-Myers Squibb's Stock Topples as Kidney Cancer Drug Flunks Phase III Study
Business
Bristol-Myers Squibb Inks Two Separate Pacts With Biogen and Roche For a Total of Up to $1.1B
April 13, 2017
 · 
3 min read
Business
How Much Biogen’s Top-Selling MS Drug Sales Could Fall by 2020
April 10, 2017
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Ionis completes enrollment in pivotal cohort of the Phase 3 REVEAL study evaluating obudanersen in Angelman syndrome
July 6, 2026
 · 
6 min read
Press Releases
Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow
July 1, 2026
 · 
8 min read
Press Releases
Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen
June 29, 2026
 · 
13 min read
Press Releases
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
June 18, 2026
 · 
8 min read
Press Releases
New Progress Toward Public Reimbursement of SKYCLARYS™ for People Living with Friedreich Ataxia in Quebec
June 8, 2026
 · 
4 min read
Press Releases
FNIH Names Recipients of the 2026 Charles A. Sanders, MD, Partnership Award
June 4, 2026
 · 
3 min read
Press Releases
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
June 4, 2026
 · 
13 min read
Press Releases
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
June 4, 2026
 · 
18 min read
Press Releases
Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses
June 3, 2026
 · 
20 min read
Press Releases
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus
June 1, 2026
 · 
16 min read
Load More